SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
Nov
Lv1
30 积分
2022-09-14 加入
最近求助
最近应助
互助留言
High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse
1个月前
已完结
Have we been qualifying measurable residual disease correctly?
1个月前
已完结
Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients
1个月前
已完结
Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study
2个月前
已完结
Evaluating the treatment of cutaneous adverse events and adherence to National Comprehensive Cancer Network guidelines in patients receiving immune checkpoint inhibitors
3个月前
已完结
SOHO State of the Art Updates and Next Questions: Mini-Hyper-CVD Combinations for Older Adults: Results of Recent Trials and a Glimpse into the Future
3个月前
已完结
Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study
3个月前
已完结
Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial
3个月前
已完结
CAR T-Cell Therapy in the Older Person: Indications and Risks
3个月前
已完结
Ph-like acute lymphoblastic leukemia in adults: understanding pathogenesis, improving outcomes, and future directions for therapy
3个月前
已完结
没有进行任何应助
速度真快
3个月前
速度真快
3个月前
帮大忙了
3个月前
速度真快
3个月前
已找到【积分已退回】
3个月前
已找到【积分已退回】
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论